Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
CC transcript
|
|
Chelsea Therapeutics International, Ltd. (CHTP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/28/2014 |
SC 13G
| RTW INVESTMENTS, LLC reports a 5.4% stake in Chelsea Therapeutics International Ltd. |
| 02/14/2014 |
SC 13G
| BAKER BROS. ADVISORS LP reports a 8.2% stake in Chelsea Therapeutics International, Ltd. |
| 01/28/2014 |
SC 13G
| BlackRock Inc. reports a 7.2% stake in CHELSEA THERAPEUTICS INTERNATIONAL |
| 11/09/2010 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 03/15/2010 |
SC 13G
| VENROCK HEALTHCARE CAPITAL PARTNERS LP reports a |
| 03/08/2010 |
SC 13G
| Senator Investment Group LP reports a 7.5% stake in CHELSEA THERAPEUTICS INTERNATIONAL, LTD. |
| 11/13/2007 |
SC 13G
| Ridgeback Capital Investments Ltd. reports a 9.5% stake in 1 Chelsea Therapeutics International, Inc. |
| 04/19/2007 |
SC 13G
| Lipschutz Lester E reports a 16.2% stake in Chelsea Therapeutics International, Ltd. |
| 02/26/2007 |
SC 13G
| Visium Balanced Fund LP reports a 8.5% stake in CHELSEA THERAPEUTICS INTERNATIONAL, LTD. |
| 02/15/2007 |
SC 13G
| DAVIDSON KEMPNER PARTNERS reports a 5.2% stake in CHELSEA THERAPEUTICS INTERNATIONAL, LTD. |
| 10/13/2006 |
SC 13G
| RA CAPITAL MANAGEMENT, LLC has filed a Schedule 13D for Chelsea Therapeutics International, Ltd. |
| 02/27/2006 |
SC 13G
| HealthCor Management, L.P. reports a 11.5% stake in CHELSEA THERAPEUTICS INTERNATIONAL, LTD. |
| 02/17/2006 |
SC 13G
| GREAT POINT PARTNERS LLC reports a 6% stake in CHELSEA THERAPEUTICS INTERNATIONAL, LTD. |
|
|